Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Participant Recruitment
2.2. Blood Collection, Lipid, and RBC Fatty Acid Analysis
2.3. DNA Isolation and RAGE G82S Gene Polymorphism
2.4. Glucose and Glyoxal Analysis
2.5. Total Fluorescent AGEs, CML Levels and sRAGE Analysis
2.6. Statistical Analysis
3. Results
3.1. Study Population Characteristics
3.2. Association of RBC C18:1, MUFA and Total sRAGE
3.3. Relationship between C18:1 and RAGE G82S Polymorphism
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Donnellan, L.; Simpson, B.; Dhillon, V.S.; Costabile, M.; Fenech, M.; Deo, P. Methylglyoxal induces chromosomal instability and mitotic dysfunction in lymphocytes. Mutagenesis 2021, 36, 339–348. [Google Scholar] [CrossRef] [PubMed]
- Thorpe, S.R.; Baynes, J.W. Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids 2003, 25, 275–281. [Google Scholar] [CrossRef] [PubMed]
- Deo, P.; McCullough, C.L.; Almond, T.; Jaunay, E.L.; Donnellan, L.; Dhillon, V.S.; Fenech, M. Dietary sugars and related endogenous advanced glycation end-products increase chromosomal DNA damage in WIL2-NS cells, measured using cytokinesis-block micronucleus cytome assay. Mutagenesis 2020, 35, 169–177. [Google Scholar] [CrossRef] [PubMed]
- Erusalimsky, J.D. The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes. Redox Biol. 2021, 42, 101958. [Google Scholar] [CrossRef]
- Shen, C.Y.; Lu, C.H.; Wu, C.H.; Li, K.J.; Kuo, Y.M.; Hsieh, S.C.; Yu, C.L. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases. Molecules 2020, 25, 5591. [Google Scholar] [CrossRef]
- Giacco, F.; Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107, 1058–1070. [Google Scholar] [CrossRef] [Green Version]
- Serveaux-Dancer, M.; Jabaudon, M.; Creveaux, I.; Belville, C.; Blondonnet, R.; Gross, C.; Constantin, J.M.; Blanchon, L.; Sapin, V. Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism. Dis. Markers 2019, 2019, 2067353. [Google Scholar] [CrossRef] [Green Version]
- Gaens, K.H.; Ferreira, I.; van der Kallen, C.J.; van Greevenbroek, M.M.; Blaak, E.E.; Feskens, E.J.; Dekker, J.M.; Nijpels, G.; Heine, R.J.; t Hart, L.M.; et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J. Clin. Endocrinol. Metab. 2009, 94, 5174–5180. [Google Scholar] [CrossRef] [Green Version]
- Miller, S.; Henry, A.P.; Hodge, E.; Kheirallah, A.K.; Billington, C.K.; Rimington, T.L.; Bhaker, S.K.; Obeidat, M.; Melén, E.; Merid, S.K.; et al. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro. PLoS ONE 2016, 11, e0164041. [Google Scholar] [CrossRef] [Green Version]
- Lyu, Y.; Zhao, H.; Ye, Y.; Liu, L.; Zhu, S.; Xia, Y.; Zou, F.; Cai, S. Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants. Mol. Med. Rep. 2018, 17, 4131–4137. [Google Scholar] [CrossRef] [Green Version]
- Clifton, P.M.; Keogh, J.B. A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease. Nutr. Metab. Cardiovasc. Dis. 2017, 27, 1060–1080. [Google Scholar] [CrossRef]
- Calder, P.C. Functional Roles of Fatty Acids and Their Effects on Human Health. JPEN J. Parenter. Enteral Nutr. 2015, 39 (Suppl. 1), 18s–32s. [Google Scholar] [CrossRef]
- Yubero-Serrano, E.M.; Garcia-Rios, A.; Delgado-Lista, J.; Delgado-Casado, N.; Perez-Martinez, P.; Rodriguez-Cantalejo, F.; Fuentes, F.; Cruz-Teno, C.; Tunez, I.; Tasset-Cuevas, I.; et al. Postprandial effects of the Mediterranean diet on oxidant and antioxidant status in elderly men and women. J. Am. Geriatr. Soc. 2011, 59, 938–940. [Google Scholar] [CrossRef]
- Shannon, O.M.; Ashor, A.W.; Scialo, F.; Saretzki, G.; Martin-Ruiz, C.; Lara, J.; Matu, J.; Griffiths, A.; Robinson, N.; Lillà, L.; et al. Mediterranean diet and the hallmarks of ageing. Eur. J. Clin. Nutr. 2021, 75, 1176–1192. [Google Scholar] [CrossRef]
- Lopez-Moreno, J.; Quintana-Navarro, G.M.; Camargo, A.; Jimenez-Lucena, R.; Delgado-Lista, J.; Marin, C.; Tinahones, F.J.; Striker, G.E.; Roche, H.M.; Perez-Martinez, P.; et al. Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome. Mol. Nutr. Food Res. 2017, 61. [Google Scholar] [CrossRef]
- Perez-Martinez, P.; Garcia-Quintana, J.M.; Yubero-Serrano, E.M.; Tasset-Cuevas, I.; Tunez, I.; Garcia-Rios, A.; Delgado-Lista, J.; Marin, C.; Perez-Jimenez, F.; Roche, H.M.; et al. Postprandial oxidative stress is modified by dietary fat: Evidence from a human intervention study. Clin. Sci. 2010, 119, 251–261. [Google Scholar] [CrossRef] [Green Version]
- Alkhatib, A.; Tsang, C.; Tuomilehto, J. Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle. Int. J. Mol. Sci. 2018, 19, 2024. [Google Scholar] [CrossRef] [Green Version]
- Crespo, M.C.; Tomé-Carneiro, J.; Dávalos, A.; Visioli, F. Pharma-Nutritional Properties of Olive Oil Phenols. Transfer of New Findings to Human Nutrition. Foods 2018, 7, 90. [Google Scholar] [CrossRef] [Green Version]
- Angeloni, C.; Malaguti, M.; Barbalace, M.C.; Hrelia, S. Bioactivity of Olive Oil Phenols in Neuroprotection. Int. J. Mol. Sci. 2017, 18, 2230. [Google Scholar] [CrossRef] [Green Version]
- Deo, P.; Dhillon, V.S.; Thomas, P.; Fenech, M. The Association of Nε-Carboxymethyllysine with Polyunsaturated and Saturated Fatty Acids in Healthy Individuals. J. Gerontol. A Biol. Sci. Med. Sci. 2022, 77, 462–470. [Google Scholar] [CrossRef]
- Dhillon, V.S.; Deo, P.; Chua, A.; Thomas, P.; Fenech, M. Telomere Length in Healthy Adults Is Positively Associated With Polyunsaturated Fatty Acids, Including Arachidonic Acid, and Negatively With Saturated Fatty Acids. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 3–6. [Google Scholar] [CrossRef] [PubMed]
- Daborg, J.; von Otter, M.; Sjölander, A.; Nilsson, S.; Minthon, L.; Gustafson, D.R.; Skoog, I.; Blennow, K.; Zetterberg, H. Association of the RAGE G82S polymorphism with Alzheimer’s disease. J. Neural Transm. 2010, 117, 861–867. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deo, P.; Dhillon, V.S.; Chua, A.; Thomas, P.; Fenech, M. APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism. J. Gerontol. A Biol. Sci. Med. Sci. 2020, 75, 1899–1905. [Google Scholar] [CrossRef] [PubMed]
- Deo, P.; Keogh, J.B.; Price, N.J.; Clifton, P.M. Effects of Weight Loss on Advanced Glycation End Products in Subjects with and without Diabetes: A Preliminary Report. Int. J. Environ. Res. Public Health 2017, 14, 1553. [Google Scholar] [CrossRef] [Green Version]
- Schuchardt, J.P.; Cerrato, M.; Ceseri, M.; DeFina, L.F.; Delgado, G.E.; Gellert, S.; Hahn, A.; Howard, B.V.; Kadota, A.; Kleber, M.E.; et al. Red blood cell fatty acid patterns from 7 countries: Focus on the Omega-3 index. Prostaglandins Leukot. Essent. Fat. Acids 2022, 179, 102418. [Google Scholar] [CrossRef]
- Momma, H.; Niu, K.; Kobayashi, Y.; Huang, C.; Chujo, M.; Otomo, A.; Tadaura, H.; Miyata, T.; Nagatomi, R. Lower serum endogenous secretory receptor for advanced glycation end product level as a risk factor of metabolic syndrome among Japanese adult men: A 2-year longitudinal study. J. Clin. Endocrinol. Metab. 2014, 99, 587–593. [Google Scholar] [CrossRef] [Green Version]
- Dozio, E.; Briganti, S.; Delnevo, A.; Vianello, E.; Ermetici, F.; Secchi, F.; Sardanelli, F.; Morricone, L.; Malavazos, A.E.; Corsi Romanelli, M.M. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women. Eur. J. Nutr. 2017, 56, 2557–2564. [Google Scholar] [CrossRef] [Green Version]
- Di Pino, A.; Urbano, F.; Zagami, R.M.; Filippello, A.; Di Mauro, S.; Piro, S.; Purrello, F.; Rabuazzo, A.M. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes. J. Clin. Endocrinol. Metab. 2016, 101, 1701–1709. [Google Scholar] [CrossRef] [Green Version]
- Challier, M.; Jacqueminet, S.; Benabdesselam, O.; Grimaldi, A.; Beaudeux, J.L. Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes. Clin. Chem. 2005, 51, 1749–1750. [Google Scholar] [CrossRef] [Green Version]
- Nakamura, K.; Yamagishi, S.; Adachi, H.; Kurita-Nakamura, Y.; Matsui, T.; Yoshida, T.; Imaizumi, T. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol. Med. 2007, 13, 185–189. [Google Scholar] [CrossRef]
- Semba, R.D.; Ferrucci, L.; Fink, J.C.; Sun, K.; Beck, J.; Dalal, M.; Guralnik, J.M.; Fried, L.P. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am. J. Kidney Dis. 2009, 53, 51–58. [Google Scholar] [CrossRef] [Green Version]
- Prasad, K.; Mishra, M. AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease. Int. J. Angiol. 2018, 27, 1–12. [Google Scholar] [CrossRef]
- Scavello, F.; Tedesco, C.C.; Castiglione, S.; Maciag, A.; Sangalli, E.; Veglia, F.; Spinetti, G.; Puca, A.A.; Raucci, A. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals. Biomark. Med. 2021, 15, 785–796. [Google Scholar] [CrossRef]
- Scavello, F.; Zeni, F.; Tedesco, C.C.; Mensà, E.; Veglia, F.; Procopio, A.D.; Bonfigli, A.R.; Olivieri, F.; Raucci, A. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging. Aging 2019, 11, 1648–1663. [Google Scholar] [CrossRef]
- Lopez-Moreno, J.; Quintana-Navarro, G.M.; Delgado-Lista, J.; Garcia-Rios, A.; Alcala-Diaz, J.F.; Gomez-Delgado, F.; Camargo, A.; Perez-Martinez, P.; Tinahones, F.J.; Striker, G.E.; et al. Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women. J. Gerontol. A Biol. Sci. Med. Sci. 2018, 73, 340–346. [Google Scholar] [CrossRef] [Green Version]
- Gutierrez-Mariscal, F.M.; Cardelo, M.P.; de la Cruz, S.; Alcala-Diaz, J.F.; Roncero-Ramos, I.; Guler, I.; Vals-Delgado, C.; López-Moreno, A.; Luque, R.M.; Delgado-Lista, J.; et al. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. Mol. Nutr. Food Res. 2021, 65, e1901290. [Google Scholar] [CrossRef]
- Ataç, Z.S.; Alaylıoğlu, M.; Dursun, E.; Gezen-Ak, D.; Yılmazer, S.; Gürvit, H. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer’s type patients in Turkish population. J. Clin. Neurosci. 2019, 59, 197–201. [Google Scholar] [CrossRef]
- Zhang, L.; Bukulin, M.; Kojro, E.; Roth, A.; Metz, V.V.; Fahrenholz, F.; Nawroth, P.P.; Bierhaus, A.; Postina, R. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J. Biol. Chem. 2008, 283, 35507–35516. [Google Scholar] [CrossRef] [Green Version]
- Miyoshi, A.; Koyama, S.; Sasagawa-Monden, M.; Kadoya, M.; Konishi, K.; Shoji, T.; Inaba, M.; Yamamoto, Y.; Koyama, H. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products. FASEB J. 2019, 33, 3575–3589. [Google Scholar] [CrossRef]
- Galichet, A.; Weibel, M.; Heizmann, C.W. Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem. Biophys. Res. Commun. 2008, 370, 1–5. [Google Scholar] [CrossRef]
- Soto-Guzman, A.; Navarro-Tito, N.; Castro-Sanchez, L.; Martinez-Orozco, R.; Salazar, E.P. Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin. Exp. Metastasis 2010, 27, 505–515. [Google Scholar] [CrossRef] [PubMed]
- Siafaka-Kapadai, A.; Hanahan, D.J.; Javors, M.A. Oleic acid-induced Ca2+ mobilization in human platelets: Is oleic acid an intracellular messenger? J. Lipid Mediat. Cell. Signal. 1997, 15, 215–232. [Google Scholar] [CrossRef] [PubMed]
- Hidalgo, M.A.; Nahuelpan, C.; Manosalva, C.; Jara, E.; Carretta, M.D.; Conejeros, I.; Loaiza, A.; Chihuailaf, R.; Burgos, R.A. Oleic acid induces intracellular calcium mobilization, MAPK phosphorylation, superoxide production and granule release in bovine neutrophils. Biochem. Biophys. Res. Commun. 2011, 409, 280–286. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Yang, L.; Conde-Knape, K.; Beher, D.; Shearman, M.S.; Shachter, N.S. Fatty acids increase presenilin-1 levels and [gamma]-secretase activity in PSwt-1 cells. J. Lipid Res. 2004, 45, 2368–2376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Amtul, Z.; Uhrig, M.; Beyreuther, K. Additive effects of fatty acid mixtures on the levels and ratio of amyloid β40/42 peptides differ from the effects of individual fatty acids. J. Neurosci. Res. 2011, 89, 1795–1801. [Google Scholar] [CrossRef]
- Liu, X.Y.; Li, H.L.; Su, J.B.; Ding, F.H.; Zhao, J.J.; Chai, F.; Li, Y.X.; Cui, S.C.; Sun, F.Y.; Wu, Z.Y.; et al. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis. J. Neurochem. 2015, 133, 187–198. [Google Scholar] [CrossRef]
- Pastor, R.; Bouzas, C.; Tur, J.A. Beneficial effects of dietary supplementation with olive oil, oleic acid, or hydroxytyrosol in metabolic syndrome: Systematic review and meta-analysis. Free Radic. Biol. Med. 2021, 172, 372–385. [Google Scholar] [CrossRef]
- Pérez-Martínez, P.; García-Ríos, A.; Delgado-Lista, J.; Pérez-Jiménez, F.; López-Miranda, J. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr. Pharm. Des. 2011, 17, 769–777. [Google Scholar] [CrossRef] [Green Version]
- Ryan, M.; McInerney, D.; Owens, D.; Collins, P.; Johnson, A.; Tomkin, G.H. Diabetes and the Mediterranean diet: A beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. Qjm 2000, 93, 85–91. [Google Scholar] [CrossRef] [Green Version]
- Yonekura, H.; Yamamoto, Y.; Sakurai, S.; Petrova, R.G.; Abedin, M.J.; Li, H.; Yasui, K.; Takeuchi, M.; Makita, Z.; Takasawa, S.; et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 2003, 370, 1097–1109. [Google Scholar] [CrossRef] [Green Version]
Variables | Value |
---|---|
Male sex, n (%) | 36 (20.7) |
Age (years) | 53.74 ± 0.61 |
BMI (kg/m2) | 26.52 ± 0.37 |
Lipid profiles | |
Total cholesterol (mmol/L) | 5.42 ± 0.07 |
HDL cholesterol (mmol/L) | 1.65 ± 0.03 |
LDL cholesterol (mmol/L) | 3.27 ± 0.06 |
Triglycerides (mmol/L) | 1.10 ± 0.04 |
Glycation biomarkers | |
Glucose (mmol/L) | 4.54 ± 0.07 |
Glyoxal (nmol/L) | 13.93 ± 0.24 |
Fluorescent AGEs (AU/mL) | 2620.43 ± 63.85 |
Nε-Carboxymethyllysine (μmol CML/mol lysine) | 48.94 ± 0.51 |
sRAGE (pg/mL) | 659.12 ± 22.49 |
RAGE G82S Polymorphism | p-Value | ||
---|---|---|---|
AG + AA (n = 20) | GG (n = 152) | ||
Glucose (mmol/L) | 4.76 ± 0.16 | 4.51 ± 0.07 | 0.155 |
Glyoxal (nmol/L) | 15.34 ± 0.75 | 13.75 ± 0.25 | 0.057 |
Fluorescent AGEs (AU/mL) | 2861.58 ± 242.80 | 2588.70 ± 64.50 | 0.289 |
Nε-Carboxymethyllysine (μmol CML/mol lysine) | 50.81 ± 1.58 | 48.77 ± 0.53 | 0.271 |
sRAGE (pg/mL) | 517.38 ± 35.77 | 677.77 ± 24.57 | 0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Deo, P.; Dhillon, V.S.; Thomas, P.; Fenech, M. Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism. Cells 2023, 12, 1662. https://0-doi-org.brum.beds.ac.uk/10.3390/cells12121662
Deo P, Dhillon VS, Thomas P, Fenech M. Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism. Cells. 2023; 12(12):1662. https://0-doi-org.brum.beds.ac.uk/10.3390/cells12121662
Chicago/Turabian StyleDeo, Permal, Varinderpal S. Dhillon, Philip Thomas, and Michael Fenech. 2023. "Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism" Cells 12, no. 12: 1662. https://0-doi-org.brum.beds.ac.uk/10.3390/cells12121662